The Latest Cardiac and Vascular News
NEWARK, Del., Oct. 26, 2017 /PRNewswire/ — More than 10 million people from 6,600 companies participated in the survey process for the World’s Best Workplaces list, sharing their perspectives on their work environment. And for the sixth consecutive year, W. L. Gore & Associates is among just 25 companies to earn a spot on the […]
HOUSTON–(BUSINESS WIRE)–October 26, 2017– CorInnova Inc., an emerging medical device company developing novel technology for the treatment of Heart Failure, announced today three milestone events: (1) the Company has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic […]
MURRAY HILL, N.J.–(BUSINESS WIRE)– C.R. Bard (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial data on its website related to this earnings release. Third quarter 2017 net sales were $989.8 million, an increase of 5 percent over the prior-year period on an as-reported basis. Excluding the […]
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.7 million were flat versus first quarter last year Gross margin increased to 81.5% from 81.0% in the prior-year period Net loss was $(2.0) […]
SAN ANTONIO, Oct. 26, 2017 /PRNewswire/ — CeloNova BioSciences, a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced that the U.S. Federal Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary COBRA PzF™ NanoCoated Coronary […]
A new study has found females and minorities have a greater risk of restenosis and subsequent MACE than “white” men after receiving everolimus-eluting stent implantation. The Study Setup A cohort study that pulled thousands of patients from both the PLATINUM Diversity and PROMUS Element Plus Post-Approval looked at groups of men, women […]
SAN FRANCISCO–(BUSINESS WIRE)–Bay Labs, a medical technology company at the forefront of applying artificial intelligence to cardiovascular imaging, today announced that Emeritus Professor of Medicine (Cardiology) at Emory University School of Medicine and the company’s Chief Medical Officer Randolph P. Martin, M.D. FACC, FASE, has been invited to be a […]
WASHINGTON, Oct. 25, 2017 /PRNewswire/ – Baylis Medical Company, a leading developer, manufacturer, and supplier of state-of-the-art interventional cardiology products, has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association’s (AdvaMed) Accel Board of Directors. “I am honoured to be appointed to the AdvaMed Accel Board and look forward to […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release financial and business results for the second quarter of 2017 after the close of trading on Tuesday, November 7, 2017. The Company’s management team will host a corresponding conference call beginning […]
KFAR SABA, Israel, Oct. 24, 2017 /PRNewswire/ — Cathworks, a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today that the first patient has been enrolled in the FAST-FFR (FFRangio Accuracy vs. STandard FFR) clinical trial. This global pivotal trial is designed to assess the efficacy […]
